News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Gleason score 6 – Should we keep calling it cancer?
Roderick van den Bergh/prostaatkankerstichting.nl
Dec 2, 2024, 22:38

Gleason score 6 – Should we keep calling it cancer?

Bárbara Melão, Urologist in Oncology Department, Manaus Adventist Hospital, shared a post on X:

“PROSCA24. Gleason score 6: should we keep calling it cancer?

Presenter: Roderick van den Bergh

  • No But we need surveillance
  • It doesn’t metastasize
  • 14% upgrading 1
  • 2-24% true progression
  • Use of risk factors could estimate the risk of true cancer.”

Gleason score

For more updates, follow OncoDaily.

Bárbara Melão cancer Manaus Adventist Hospital Memorial Sloan Kettering metastasize OncoDaily Oncology risk of cancer Roderick van den Bergh
Special Coverage
Blog
Dec 2, 2024, 22:38
Gleason score 6 - Should we keep calling it cancer?
Blog
Dec 2, 2024, 22:36
How does the management change if the patient is older and frail?
Blog
Dec 2, 2024, 22:34
Naveen Pemmaraju: ASH Hematology Session on Patient Care, Research and Education on Rare Disease
Insight
Dec 2, 2024, 22:27
Survival Outcomes with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer
Blog
Dec 2, 2024, 21:45
Shaibu Issa: Did you Know hepatitis B and HIV can be treated with the same medicines?
Blog
Dec 2, 2024, 21:38
ASCO24 Updates: Paraic Kenny on Gundersen Precision Oncology Cohort
Blog
Dec 2, 2024, 21:31
Emad Shash: The power of public influencers and media voices in shaping health awareness
Blog
Dec 2, 2024, 21:30
The Max Foundation - Pharma companies still not maximising their potential to reach more patients in LMICs
Blog
Dec 2, 2024, 20:23
Lung Cancer: Know the Risks, Take Action - Cancer Fight Tanzania
Blog
Dec 2, 2024, 20:19
Zwelethu Bashman: Honored to have participated in the Africa CDC Continental Consultative Meeting
Blog
Dec 2, 2024, 20:14
Rasha Aboelhassan: MDT is the cornerstone for treatment decisions, especially for HCC patients
Insight
Dec 2, 2024, 20:05
Xiuning Le: RTK fusion-mediated resistance to EGFR-TKI in EGFR-mutated NSCLC